The global Upper-Limb Rehabilitation Exoskeleton Robot market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Upper-Limb Rehabilitation Exoskeleton Robot is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Upper-Limb Rehabilitation Exoskeleton Robot is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Upper-Limb Rehabilitation Exoskeleton Robot is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Upper-Limb Rehabilitation Exoskeleton Robot players cover AiBle, MIT Manus (InMotion), BIONIK, ATOUN, CYBERDYNE, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淯pper-Limb Rehabilitation Exoskeleton Robot Industry Forecast鈥� looks at past sales and reviews total world Upper-Limb Rehabilitation Exoskeleton Robot sales in 2024, providing a comprehensive analysis by region and market sector of projected Upper-Limb Rehabilitation Exoskeleton Robot sales for 2025 through 2031. With Upper-Limb Rehabilitation Exoskeleton Robot sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Upper-Limb Rehabilitation Exoskeleton Robot industry.
This Insight Report provides a comprehensive analysis of the global Upper-Limb Rehabilitation Exoskeleton Robot landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Upper-Limb Rehabilitation Exoskeleton Robot portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Upper-Limb Rehabilitation Exoskeleton Robot market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Upper-Limb Rehabilitation Exoskeleton Robot and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Upper-Limb Rehabilitation Exoskeleton Robot.
This report presents a comprehensive overview, market shares, and growth opportunities of Upper-Limb Rehabilitation Exoskeleton Robot market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Based on AI
Cloud Computing
Segmentation by Application:
Hospital
Rehabilitation Centres
麻豆原创 Care
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
AiBle
MIT Manus (InMotion)
BIONIK
ATOUN
CYBERDYNE
Honda Motor
ReWalk Robotics
Rex Bionics
Sarcos
Technaid
U.s. Bionics
Ekso Bionics
Hocoma
Panasonic
B-TEMIA
SuitX
Ulsrobotics
MEBOTX
Buffalo-Robot
Key Questions Addressed in this Report
What is the 10-year outlook for the global Upper-Limb Rehabilitation Exoskeleton Robot market?
What factors are driving Upper-Limb Rehabilitation Exoskeleton Robot market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Upper-Limb Rehabilitation Exoskeleton Robot market opportunities vary by end market size?
How does Upper-Limb Rehabilitation Exoskeleton Robot break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Upper-Limb Rehabilitation Exoskeleton Robot Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Upper-Limb Rehabilitation Exoskeleton Robot by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Upper-Limb Rehabilitation Exoskeleton Robot by Country/Region, 2020, 2024 & 2031
2.2 Upper-Limb Rehabilitation Exoskeleton Robot Segment by Type
2.2.1 Based on AI
2.2.2 Cloud Computing
2.3 Upper-Limb Rehabilitation Exoskeleton Robot Sales by Type
2.3.1 Global Upper-Limb Rehabilitation Exoskeleton Robot Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Upper-Limb Rehabilitation Exoskeleton Robot Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Upper-Limb Rehabilitation Exoskeleton Robot Sale Price by Type (2020-2025)
2.4 Upper-Limb Rehabilitation Exoskeleton Robot Segment by Application
2.4.1 Hospital
2.4.2 Rehabilitation Centres
2.4.3 麻豆原创 Care
2.4.4 Others
2.5 Upper-Limb Rehabilitation Exoskeleton Robot Sales by Application
2.5.1 Global Upper-Limb Rehabilitation Exoskeleton Robot Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Upper-Limb Rehabilitation Exoskeleton Robot Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Upper-Limb Rehabilitation Exoskeleton Robot Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Upper-Limb Rehabilitation Exoskeleton Robot Breakdown Data by Company
3.1.1 Global Upper-Limb Rehabilitation Exoskeleton Robot Annual Sales by Company (2020-2025)
3.1.2 Global Upper-Limb Rehabilitation Exoskeleton Robot Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Upper-Limb Rehabilitation Exoskeleton Robot Annual Revenue by Company (2020-2025)
3.2.1 Global Upper-Limb Rehabilitation Exoskeleton Robot Revenue by Company (2020-2025)
3.2.2 Global Upper-Limb Rehabilitation Exoskeleton Robot Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Upper-Limb Rehabilitation Exoskeleton Robot Sale Price by Company
3.4 Key Manufacturers Upper-Limb Rehabilitation Exoskeleton Robot Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Upper-Limb Rehabilitation Exoskeleton Robot Product Location Distribution
3.4.2 Players Upper-Limb Rehabilitation Exoskeleton Robot Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Upper-Limb Rehabilitation Exoskeleton Robot by Geographic Region
4.1 World Historic Upper-Limb Rehabilitation Exoskeleton Robot 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Upper-Limb Rehabilitation Exoskeleton Robot Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Upper-Limb Rehabilitation Exoskeleton Robot Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Upper-Limb Rehabilitation Exoskeleton Robot 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Upper-Limb Rehabilitation Exoskeleton Robot Annual Sales by Country/Region (2020-2025)
4.2.2 Global Upper-Limb Rehabilitation Exoskeleton Robot Annual Revenue by Country/Region (2020-2025)
4.3 Americas Upper-Limb Rehabilitation Exoskeleton Robot Sales Growth
4.4 APAC Upper-Limb Rehabilitation Exoskeleton Robot Sales Growth
4.5 Europe Upper-Limb Rehabilitation Exoskeleton Robot Sales Growth
4.6 Middle East & Africa Upper-Limb Rehabilitation Exoskeleton Robot Sales Growth
5 Americas
5.1 Americas Upper-Limb Rehabilitation Exoskeleton Robot Sales by Country
5.1.1 Americas Upper-Limb Rehabilitation Exoskeleton Robot Sales by Country (2020-2025)
5.1.2 Americas Upper-Limb Rehabilitation Exoskeleton Robot Revenue by Country (2020-2025)
5.2 Americas Upper-Limb Rehabilitation Exoskeleton Robot Sales by Type (2020-2025)
5.3 Americas Upper-Limb Rehabilitation Exoskeleton Robot Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Upper-Limb Rehabilitation Exoskeleton Robot Sales by Region
6.1.1 APAC Upper-Limb Rehabilitation Exoskeleton Robot Sales by Region (2020-2025)
6.1.2 APAC Upper-Limb Rehabilitation Exoskeleton Robot Revenue by Region (2020-2025)
6.2 APAC Upper-Limb Rehabilitation Exoskeleton Robot Sales by Type (2020-2025)
6.3 APAC Upper-Limb Rehabilitation Exoskeleton Robot Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Upper-Limb Rehabilitation Exoskeleton Robot by Country
7.1.1 Europe Upper-Limb Rehabilitation Exoskeleton Robot Sales by Country (2020-2025)
7.1.2 Europe Upper-Limb Rehabilitation Exoskeleton Robot Revenue by Country (2020-2025)
7.2 Europe Upper-Limb Rehabilitation Exoskeleton Robot Sales by Type (2020-2025)
7.3 Europe Upper-Limb Rehabilitation Exoskeleton Robot Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Upper-Limb Rehabilitation Exoskeleton Robot by Country
8.1.1 Middle East & Africa Upper-Limb Rehabilitation Exoskeleton Robot Sales by Country (2020-2025)
8.1.2 Middle East & Africa Upper-Limb Rehabilitation Exoskeleton Robot Revenue by Country (2020-2025)
8.2 Middle East & Africa Upper-Limb Rehabilitation Exoskeleton Robot Sales by Type (2020-2025)
8.3 Middle East & Africa Upper-Limb Rehabilitation Exoskeleton Robot Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Upper-Limb Rehabilitation Exoskeleton Robot
10.3 Manufacturing Process Analysis of Upper-Limb Rehabilitation Exoskeleton Robot
10.4 Industry Chain Structure of Upper-Limb Rehabilitation Exoskeleton Robot
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Upper-Limb Rehabilitation Exoskeleton Robot Distributors
11.3 Upper-Limb Rehabilitation Exoskeleton Robot Customer
12 World Forecast Review for Upper-Limb Rehabilitation Exoskeleton Robot by Geographic Region
12.1 Global Upper-Limb Rehabilitation Exoskeleton Robot 麻豆原创 Size Forecast by Region
12.1.1 Global Upper-Limb Rehabilitation Exoskeleton Robot Forecast by Region (2026-2031)
12.1.2 Global Upper-Limb Rehabilitation Exoskeleton Robot Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Upper-Limb Rehabilitation Exoskeleton Robot Forecast by Type (2026-2031)
12.7 Global Upper-Limb Rehabilitation Exoskeleton Robot Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 AiBle
13.1.1 AiBle Company Information
13.1.2 AiBle Upper-Limb Rehabilitation Exoskeleton Robot Product Portfolios and Specifications
13.1.3 AiBle Upper-Limb Rehabilitation Exoskeleton Robot Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AiBle Main Business Overview
13.1.5 AiBle Latest Developments
13.2 MIT Manus (InMotion)
13.2.1 MIT Manus (InMotion) Company Information
13.2.2 MIT Manus (InMotion) Upper-Limb Rehabilitation Exoskeleton Robot Product Portfolios and Specifications
13.2.3 MIT Manus (InMotion) Upper-Limb Rehabilitation Exoskeleton Robot Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 MIT Manus (InMotion) Main Business Overview
13.2.5 MIT Manus (InMotion) Latest Developments
13.3 BIONIK
13.3.1 BIONIK Company Information
13.3.2 BIONIK Upper-Limb Rehabilitation Exoskeleton Robot Product Portfolios and Specifications
13.3.3 BIONIK Upper-Limb Rehabilitation Exoskeleton Robot Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 BIONIK Main Business Overview
13.3.5 BIONIK Latest Developments
13.4 ATOUN
13.4.1 ATOUN Company Information
13.4.2 ATOUN Upper-Limb Rehabilitation Exoskeleton Robot Product Portfolios and Specifications
13.4.3 ATOUN Upper-Limb Rehabilitation Exoskeleton Robot Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 ATOUN Main Business Overview
13.4.5 ATOUN Latest Developments
13.5 CYBERDYNE
13.5.1 CYBERDYNE Company Information
13.5.2 CYBERDYNE Upper-Limb Rehabilitation Exoskeleton Robot Product Portfolios and Specifications
13.5.3 CYBERDYNE Upper-Limb Rehabilitation Exoskeleton Robot Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 CYBERDYNE Main Business Overview
13.5.5 CYBERDYNE Latest Developments
13.6 Honda Motor
13.6.1 Honda Motor Company Information
13.6.2 Honda Motor Upper-Limb Rehabilitation Exoskeleton Robot Product Portfolios and Specifications
13.6.3 Honda Motor Upper-Limb Rehabilitation Exoskeleton Robot Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Honda Motor Main Business Overview
13.6.5 Honda Motor Latest Developments
13.7 ReWalk Robotics
13.7.1 ReWalk Robotics Company Information
13.7.2 ReWalk Robotics Upper-Limb Rehabilitation Exoskeleton Robot Product Portfolios and Specifications
13.7.3 ReWalk Robotics Upper-Limb Rehabilitation Exoskeleton Robot Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 ReWalk Robotics Main Business Overview
13.7.5 ReWalk Robotics Latest Developments
13.8 Rex Bionics
13.8.1 Rex Bionics Company Information
13.8.2 Rex Bionics Upper-Limb Rehabilitation Exoskeleton Robot Product Portfolios and Specifications
13.8.3 Rex Bionics Upper-Limb Rehabilitation Exoskeleton Robot Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Rex Bionics Main Business Overview
13.8.5 Rex Bionics Latest Developments
13.9 Sarcos
13.9.1 Sarcos Company Information
13.9.2 Sarcos Upper-Limb Rehabilitation Exoskeleton Robot Product Portfolios and Specifications
13.9.3 Sarcos Upper-Limb Rehabilitation Exoskeleton Robot Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Sarcos Main Business Overview
13.9.5 Sarcos Latest Developments
13.10 Technaid
13.10.1 Technaid Company Information
13.10.2 Technaid Upper-Limb Rehabilitation Exoskeleton Robot Product Portfolios and Specifications
13.10.3 Technaid Upper-Limb Rehabilitation Exoskeleton Robot Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Technaid Main Business Overview
13.10.5 Technaid Latest Developments
13.11 U.s. Bionics
13.11.1 U.s. Bionics Company Information
13.11.2 U.s. Bionics Upper-Limb Rehabilitation Exoskeleton Robot Product Portfolios and Specifications
13.11.3 U.s. Bionics Upper-Limb Rehabilitation Exoskeleton Robot Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 U.s. Bionics Main Business Overview
13.11.5 U.s. Bionics Latest Developments
13.12 Ekso Bionics
13.12.1 Ekso Bionics Company Information
13.12.2 Ekso Bionics Upper-Limb Rehabilitation Exoskeleton Robot Product Portfolios and Specifications
13.12.3 Ekso Bionics Upper-Limb Rehabilitation Exoskeleton Robot Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Ekso Bionics Main Business Overview
13.12.5 Ekso Bionics Latest Developments
13.13 Hocoma
13.13.1 Hocoma Company Information
13.13.2 Hocoma Upper-Limb Rehabilitation Exoskeleton Robot Product Portfolios and Specifications
13.13.3 Hocoma Upper-Limb Rehabilitation Exoskeleton Robot Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Hocoma Main Business Overview
13.13.5 Hocoma Latest Developments
13.14 Panasonic
13.14.1 Panasonic Company Information
13.14.2 Panasonic Upper-Limb Rehabilitation Exoskeleton Robot Product Portfolios and Specifications
13.14.3 Panasonic Upper-Limb Rehabilitation Exoskeleton Robot Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Panasonic Main Business Overview
13.14.5 Panasonic Latest Developments
13.15 B-TEMIA
13.15.1 B-TEMIA Company Information
13.15.2 B-TEMIA Upper-Limb Rehabilitation Exoskeleton Robot Product Portfolios and Specifications
13.15.3 B-TEMIA Upper-Limb Rehabilitation Exoskeleton Robot Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 B-TEMIA Main Business Overview
13.15.5 B-TEMIA Latest Developments
13.16 SuitX
13.16.1 SuitX Company Information
13.16.2 SuitX Upper-Limb Rehabilitation Exoskeleton Robot Product Portfolios and Specifications
13.16.3 SuitX Upper-Limb Rehabilitation Exoskeleton Robot Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 SuitX Main Business Overview
13.16.5 SuitX Latest Developments
13.17 Ulsrobotics
13.17.1 Ulsrobotics Company Information
13.17.2 Ulsrobotics Upper-Limb Rehabilitation Exoskeleton Robot Product Portfolios and Specifications
13.17.3 Ulsrobotics Upper-Limb Rehabilitation Exoskeleton Robot Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Ulsrobotics Main Business Overview
13.17.5 Ulsrobotics Latest Developments
13.18 MEBOTX
13.18.1 MEBOTX Company Information
13.18.2 MEBOTX Upper-Limb Rehabilitation Exoskeleton Robot Product Portfolios and Specifications
13.18.3 MEBOTX Upper-Limb Rehabilitation Exoskeleton Robot Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 MEBOTX Main Business Overview
13.18.5 MEBOTX Latest Developments
13.19 Buffalo-Robot
13.19.1 Buffalo-Robot Company Information
13.19.2 Buffalo-Robot Upper-Limb Rehabilitation Exoskeleton Robot Product Portfolios and Specifications
13.19.3 Buffalo-Robot Upper-Limb Rehabilitation Exoskeleton Robot Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Buffalo-Robot Main Business Overview
13.19.5 Buffalo-Robot Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
